IHS Chemical Week

Aurobindo to acquire Hyacinths Pharma as part of APIs push

September 13, 2013

Aurobindo Pharma (Hyderabad, India) says it will acquire, from existing private shareholders, Hyacinths Pharma (Andhra Pradesh, India), a company incorporated to manufacture active pharmaceutical ingredients (APIs). Hyacinths, located near Aurobindo’s operations, has a 53-acre site at Srikakulum, India—also near Aurobindo—and all the necessary approvals to begin production of APIs. The acquisition forms part of Aurobindo’s previously announced plan to raise sales of APIs to $700 million by fiscal 2016. In fiscal 2013, the company’s APIs sales were $465...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 


Forgot your user ID or password? Click here to have it sent to you.

contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa